Please enable JavaScript.
Coggle requires JavaScript to display documents.
Block 43 Pharmacology, Sammer Sheikh - Coggle Diagram
Block 43 Pharmacology
MSK
Non-steroidal anti-inflammatory drugs (NSAIDs)
ibuprofen (non-selective)
naproxen (non-selective)
celecoxib (Cox2-selective inhibitor)
disease-modifying antirheumatic drugs (DMARDs)
sulfasalazine
hydroxychloroquine (anti-malarial)
methotrexate (antimetabolite)
leflunomide
sodium autothiomalate (gold)
azathiprine (anti-metabolite)
cliclosporin (calcineurin inhibitor)
penicillamine
antibodies against tumour necrosis factor a
adalimumab
etanercept
infliximab
biological agents
anakinra - interleukin-1 receptor antagonist
tocilizumab - interleukin-6 receptor antagonist
abatacept - T-cell co-stimulation modulator
rituximab - anti-CD20 B-cell depleter
colchicine
xanthine oxidase inhibitors
allopurinol
febuxostat
rasburicase
Surgery and anaesthesia
local anaesthetics
lidocaine
bupivacaine
intravenous anaesthetics
etomidate
ketamine
propofol
thiopental
intravenous opioids during anaesthesia
fentanyl
remifentanil
inhalational anaesthetics
desflurane
halothane
isoflurane
nitrous oxide
sevoflurane
depolarising neuromuscular-blocking drugs
suxamethonium (succinylcholine)
competitive N2 receptor antagonists (non-depolarising blockers)
atracurium
cistracurium
mivacurium
pancuronium
rocuronium
vecuronium
acetylcholinesterase inhibitors
edrophonium
neostigmine
pyridostigmine
Sammer Sheikh